This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gattorno, M Articles by Martini, A Search for Related Content PubMed PubMed Citation Articles by Gattorno, M Articles by Martini, A Social Bookmarking                         What's this?

Outcome of primary antiphospholipid syndrome in childhood

Dipartimento di Pediatria Universitàdi Genova, Pediatria II, Istituto G. Gaslini, Genova, marcogattorno{at}ospedale-gaslini.ge.it

F Falcini

Dipartimento di Pediatria, Ospedale Meyer, Universitàdi Firenze, Firenze

A Ravelli

Dipartimento di Pediatria Universitàdi Genova, Pediatria II, Istituto G. Gaslini, Genova

F Zulian

Dipartimento di Pediatria, Universitàdi Padova, Padova, Italy

A Buoncompagni

Dipartimento di Pediatria Universitàdi Genova, Pediatria II, Istituto G. Gaslini, Genova

G Martini

Dipartimento di Pediatria, Universitàdi Padova, Padova, Italy

M Resti

Dipartimento di Pediatria, Ospedale Meyer, Universitàdi Firenze, Firenze

P Picco

Dipartimento di Pediatria Universitàdi Genova, Pediatria II, Istituto G. Gaslini, Genova

A Martini

Dipartimento di Pediatria Universitàdi Genova, Pediatria II, Istituto G. Gaslini, Genova

The objective of this paper is to investigate the long-term outcome of primary antiphospholipid syndrome (APS) in the paediatric age. The features of unselected patients with primary APS who had disease onset before the age of 16 years were retrospectivelyanalysed in three Italian referral centres. Clinical and laboratory manifestationswere assessed to establish whether, at the end of follow-up, the final diagnosis was still primary APS or whether they had developed definite SLE or lupus-like syndrome.Fourteen patients, nine boys and five girls, who had the presentingclinical manifestationof APS between three and 13 years of age (median nine years) and were followed for two to 16 years (median six years). Six patients presented with deep vein thrombosis, five with cerebral stroke, two with peripheral artery occlusion and one with myocardial infarction. During follow-up, four patients had one or more recurrences of vascular thrombosis. At last observation, 10 patients could still be classified as having primary APS, two had developed SLE, one lupus-like syndrome and one Hodgkin’s lymphoma. In conclusion; our analysis suggests that some children who present with the features of primary APS may progress to develop SLE or lupus-like syndrome.

Key Words: antiphospholipid antibodies • childhood • outcome • primary antiphospholipid syndrome

Lupus, Vol. 12, No. 6, 449-453 (2003)
DOI: 10.1191/0961203303lu411oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T Avcin, R Cimaz, B Rozman, and The Ped-APS Registry Collaborative Group* The Ped-APS Registry: the antiphospholipid syndrome in childhood Lupus, September 1, 2009; 18(10): 894 - 899. [Abstract] [PDF]

				T. Avcin, R. Cimaz, E. D. Silverman, R. Cervera, M. Gattorno, S. Garay, Y. Berkun, F. R. Sztajnbok, C. A. Silva, L. M. Campos, et al. Pediatric Antiphospholipid Syndrome: Clinical and Immunologic Features of 121 Patients in an International Registry Pediatrics, November 1, 2008; 122(5): e1100 - e1107. [Abstract] [Full Text] [PDF]

				T. Avcin and E. Silverman Review: Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome Lupus, August 1, 2007; 16(8): 627 - 633. [Abstract] [PDF]

				F Falcini Vascular and connective tissue diseases in the paediatric world Lupus, February 1, 2004; 13(2): 77 - 84. [Abstract] [PDF]